2022 Clinical Guideline Toplines: Essential Summaries for Primary Care

Article

Clinical practice guidelines and treatment decision pathways for multiple therapeutic areas were updated during 2022, including those for diagnosis and management of nonalcoholic fatty liver disease, heart failure management, obesity, and preexposure prophylaxis for HIV prevention.

For time-constrained primary care clinicians, Patient Care® summarizes key additions and other changes to these evidence-based, "living" documents, in a Guideline Topline. These Toplines are at-a-glance slide shows, a convenient format to click through for the high-level kernels that may influence daily practice. (Please note that this collection is not comprehensive but reflects clinical areas frequently addressed in the primary care setting.)


Opioid guidelines 2022 CDC

Opioids for Pain Management: Guideline Topline for Primary Care

A guideline topline of the CDC's 2022 revised clinical recommendations for prescribing opioids for pain in adults.

Obesity medication guidelines

Pharmacologic Interventions for Adults with Obesity: Guideline Topline for Primary Care

The American Gastroenterological Association released its first medical guideline recommending prescription medications for weight loss in adults with obesity. A review, here.

Hypertension medication to avoid American Heart Association

13 Medications to Avoid in Adults with Hypertension: A Guideline Topline for Primary Care

Reduce potential for promoting or worsening hypertension by stopping, reducing, or using alternatives to these 13 drugs and substances.

Secondary hypertension causes guidelines AHA

Causes of Secondary Hypertension: A Guideline Topline for Primary Care

Obstructive sleep apnea is a cause of secondary hypertension in up to 50% of cases; more common causes here, from the 2017 ACC/AHA hypertension guidelines.

White coat hypertension, masked hypertension guidelines

White Coat & Masked Hypertension: A Primary Care Guideline Topline

White coat and masked hypertension can be elusive and dangerous. Click through a topline look at recommendations from the 2017 ACC/AHA hypertension guidelines.

NAFLD management guidelines, primary care

Management of Nonalcoholic Fatty Liver Disease in Adults: Guidelines for Primary Care Clinicians

An overview of recommendations from the American Association of Clinical Endocrinology for the management of NAFLD in adults.

NAFLD diagnosis for primary care

Diagnosis of Nonalcoholic Fatty Liver Disease in Adults: Guidelines for Primary Care

Get an overview of the recent AACE guidelines for diagnosing NAFLD in adults in primary care settings.

NAFLD and ASCVD Risk AHA guidelines

New AHA Statement on NAFLD and Cardiovascular Risk: A Guideline Topline

NAFLD is a key risk factor for ASCVD and widely underdiagnosed. This Guideline Topline summarizes new AHA warnings, guidance.

Heart failure guidelines 2022 ACC AHA HFSA

ACC, AHA, HFSA 2022 Heart Failure Management Guidelines: A Guideline Topline

The new HF guidelines prioritize primary prevention, revise disease stages to encourage early intervention, and now include SGLT2i as guideline-directed medical therapy.

PrEP guidelines CDC 2021

PrEP for HIV Prevention: A Guideline Topline

The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.

Painful diabetic neuropathy american academy of Neurology guidelines

Painful Diabetic Neuropathy Treatment: A Guideline Topline

The American Academy of Neurology recently issued a guideline on oral and topical treatments for painful diabetic neuropathy. Here, a concise summary for clinicians.


Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
© 2024 MJH Life Sciences

All rights reserved.